Alcidion Group Limited (ASX:ALC)

Market Cap	128.98M +1.1%
Revenue (ttm)	51.64M +26.6%
Net Income	2.29M +38.2%
EPS	0.00 +41.8%
Shares Out	1.34B
PE Ratio	56.47
Forward PE	46.15
Dividend	n/a
Ex-Dividend Date	n/a

Volume	612,050
Open	0.0950
Previous Close	0.0950
Day's Range	0.0940 - 0.0970
52-Week Range	0.0830 - 0.1450
Beta	1.03
Analysts	Buy
Price Target	0.15 (+56.25%)
Est. Earnings	Oct 28, 2026

About Alcidion Group

Alcidion Group Limited, together with its subsidiaries, develops and sells digital health software solutions for healthcare organisations in Australia, New Zealand, and the United Kingdom. It offers Miya Precision, a fast healthcare interoperability resource (FHIR) events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). The company's platform also provides electronic patient flow journey boards; virtual care and remote p...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2000
• Employees: 141
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ALC

Financial Performance

In fiscal year 2026, Alcidion Group's revenue was 51.64 million, an increase of 26.61% compared to the previous year's 40.79 million. Earnings were 2.29 million, an increase of 38.15%.

Analyst Summary

According to 4 analysts, the average rating for ALC stock is "Buy." The 12-month stock price target is $0.15, which is an increase of 56.25% from the latest price.

Price Target

$0.15

(56.25% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 20, 2026

Data Sources Report a data error